. . . . . . . . . . . . . . . . "p(MGI:Vip) -| tscript(p(MGI:Nfatc2))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "VIP/PACAP inhibit the expression of Egr2 and 3, but not of Egr1. The effects on the transcriptional factors are mediated through type 2 VIP receptor with cAMP as secondary messenger." . . "Selventa" . . . . "2014-07-03T14:31:39.307+02:00"^^ . . .